Compare ASML & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASML | LLY |
|---|---|---|
| Founded | 1984 | 1876 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.2B | 979.6B |
| IPO Year | 1995 | 2007 |
| Metric | ASML | LLY |
|---|---|---|
| Price | $1,816.41 | $1,207.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | ★ $1,460.63 | $1,218.84 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 04-15-2026 | 04-30-2026 |
| Dividend Yield | 0.54% | ★ 0.81% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | N/A | ★ 16.19 |
| Revenue | N/A | ★ $65,179,000,000.00 |
| Revenue This Year | $17.80 | $27.15 |
| Revenue Next Year | $19.51 | $16.04 |
| P/E Ratio | ★ $50.62 | $73.20 |
| Revenue Growth | N/A | ★ 44.70 |
| 52 Week Low | $718.23 | $685.15 |
| 52 Week High | $1,999.96 | $1,249.45 |
| Indicator | ASML | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 54.84 |
| Support Level | $1,717.00 | $1,121.78 |
| Resistance Level | $1,979.50 | $1,240.73 |
| Average True Range (ATR) | 46.85 | 38.71 |
| MACD | 20.33 | 0.46 |
| Stochastic Oscillator | 75.69 | 74.19 |
ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's largest clients are TSMC, Samsung, Intel, SK Hynix, and Micron.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.